The goal of this study is to determine if there is an underlying hormonal basis for the variations in orthostatic tolerance in a subset of women who are orthostatically intolerant. Based on the hypothesis, supported by anecdotal reports and preliminary data that some female subjects are orthostatically much more intolerant during certain phases of their menstrual cycle, we plan to study the influence of the menstrual cycle in a subset of 10 orthostatically intolerant women, 20 orthostatically tolerant women, and 10 female patients with POTS. The female patients will undergo autonomic testing at 3 phases of their menstrual cycle for 3 months resulting in 9 evaluations. The phases will be menstrual (second or third day of the cycle), follicular pre-ovulatory (1 day before the expected day of ovulation), pre-menstrual luteal (7 days prior to day of ovulation), pre-menstrual luteal (7 day sprior to menstruation). The oral temperature will be measured each morning at the same time before arising. The last low point in the temperature curve before the rise towards the hyperthermic plateau started is considered the day of ovulation. Serum levels of 17 beta-estradiol, progesterone, serum luteinizing hormone, and follicule stimulating hormone will be measured on the morning of these 9 times. The hormone levels provide distinctive profiles of these times. We will study 17 b-estradiol, progesterone, serum luteinizing hormone and follicular stimulating hormone using RIA. Women to be evaluated must have a regular and predictable menstrual cycle and must not be taking oral contraceptive agents. The evaluation on each occasion consists of the response to tilt of 20 minutes during (cardiovascular indices), the HR response to 8 cycles of deep breathing at a rate of 6 breaths/minute and the HR and BP response to Valsalva maneuvers performed while supine. The study will be done over 3 months for each subject. On each visit, the subject, clothed in a light hospital gown, is weighed. A QSART (quantitative sudomotor axon reflex) will be performed after in the 3 visits of the fist month. A semiquantitative symptoms scale will be obtained during tilt. Patients will be graded on dizziness, tremulousness, and anxiety.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
Budget End
Support Year
29
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Kamimura, Daisuke; Suzuki, Takeki; Wang, Wanmei et al. (2018) Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Hypertens Res 41:629-638
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Tirumanisetty, P; Prichard, D; Fletcher, J G et al. (2018) Normal values for assessment of anal sphincter morphology, anorectal motion, and pelvic organ prolapse with MRI in healthy women. Neurogastroenterol Motil 30:e13314
McKenzie, Katelyn A; El Ters, Mirelle; Torres, Vicente E et al. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrol 19:378
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624
Brosnahan, Godela M; Abebe, Kaleab Z; Rahbari-Oskoui, Frederic F et al. (2017) Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials. Curr Hypertens Rev 13:109-120
Kamimura, Daisuke; Suzuki, Takeki; Furniss, Anna L et al. (2017) Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness. J Cardiovasc Med (Hagerstown) 18:954-961
Chung, Jin Ook; Koutsari, Christina; Blachnio-Zabielska, Agnieszka U et al. (2017) Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans. Diabetes 66:2082-2091
West, Nancy A; Lirette, Seth T; Cannon, Victoria A et al. (2017) Adiposity, Change in Adiposity, and Cognitive Decline in Mid- and Late Life. J Am Geriatr Soc 65:1282-1288

Showing the most recent 10 out of 1267 publications